Skip to main content

Table 6 Comparison between the numbers of patients classified as responders/non-responders using each of the three evaluations versus pathology base Miller–Payne grading

From: Quantitative mathematical objective evaluation of contrast-enhanced spectral mammogram in the assessment of response to neoadjuvant chemotherapy and prediction of residual disease in breast cancer

  Pathologic Response
Responder Non-responder
Count (n = 39) % Count (n = 3) %
Quantitative objective evaluation Responder (n = 40) 39 100% 1 33.3%
Non-responder (n = 2) 0 0% 2 66.7%
RECIST 1.1 Evaluation Responder (n = 35) 34 87.2% 1 33.3%
Non-responder (n = 7) 5 12.8% 2 66.7%
Combined response evaluation Responder (n = 39) 38 97.4% 1 33.3%
Non-responder (n = 3) 1 2.6% 2 66.7%